Bilateral breast masses as the manifestation of lung adenocarcinoma in pregnancy

CLINICAL IMAGE Lung carcinoma mimicking breast cancer 1 Computed tomography identified an infiltrative mass in the right upper lobe (31 mm 74 mm), pleural effusion, as well as multiple bone metastases, multiple liver metastases, adrenal and renal lesions, and skeletal metastases.Mammography and breast ultrasound showed bilateral irregular, well -defined, hypoechogenic breast nodules (14-19 mm; Breast Imaging Reporting and Data System, 4c).Such lesions can mimic primary BC, including triple -negative phenotypes, which is why tissue diagnosis with immunohistochemistry is the golden standard. 4FIGURE 1A-1F shows the diagnostic imaging performed.Liver biopsy demonstrated adenocarcinoma-CK7+, TTF1+, HER2-, and Ki67 of approximately 42%-consistent with pulmonary origin.Breast biopsies in both cases showed adenocarcinoma metastatis immunoprofile: CK7+/TTF1+/ER-/ PR-/HER2-/GATA3-/GCDFP-/ mammaglobin-.The result supported lung origin rather than primary breast carcinoma.Microscopic images of histology samples are presented in FIGURE 1G and1H.Key features that can distinguish between metastatic and primary breast carcinoma include: absence of an in -situ component, multiplicity / bilaterality, and a lack of breast markers, such as ER/ PR/HER2/GATA3/GCDFP/mammaglobin, with positive lung markers (TTF -1).The treatment proposed by a multidisciplinary board included stereotactic radiotherapy for brain metastases, brachytherapy for ocular metastasis, and systemic therapy (chemotherapy or immunotherapy) pending molecular testing (programmed cell death ligand 1 and next generation sequencing).The patient remained clinically stable and was discharged with follow -up scheduled for oncology, ophthalmology, radiotherapy, and palliative care.The therapy consisted of paclitaxel, gemcitabine, and radiotherapy of the brain.The treatment followed current standards of care. 5etastatic breast disease originating from lung cancer is a rare clinical condition, even rarer

Authors

Publication Details

Journal
Polskie Archiwum Medycyny Wewnętrznej
Published
2026-02-13
DOI
https://doi.org/10.20452/pamw.17229
Primary Topic
Cancer Risks and Factors
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Bilateral breast masses as the manifestation of lung adenocarcinoma in pregnancy

Elzbieta Luczynska, Wojciech Rudnicki, Joanna Szpor, Tadeusz Popiela
Polskie Archiwum Medycyny Wewnętrznej
Cancer Risks and Factors
article

Bilateral breast masses as the manifestation of lung adenocarcinoma in pregnancy

Elzbieta Luczynska, Wojciech Rudnicki, Joanna Szpor, Tadeusz Popiela
article en

Abstract

CLINICAL IMAGE Lung carcinoma mimicking breast cancer 1 Computed tomography identified an infiltrative mass in the right upper lobe (31 mm 74 mm), pleural effusion, as well as multiple bone metastases, multiple liver metastases, adrenal and renal lesions, and skeletal metastases.Mammography and breast ultrasound showed bilateral irregular, well -defined, hypoechogenic breast nodules (14-19 mm; Breast Imaging Reporting and Data System, 4c).Such lesions can mimic primary BC, including triple -negative phenotypes, which is why tissue diagnosis with immunohistochemistry is the golden standard. 4FIGURE 1A-1F shows the diagnostic imaging performed.Liver biopsy demonstrated adenocarcinoma-CK7+, TTF1+, HER2-, and Ki67 of approximately 42%-consistent with pulmonary origin.Breast biopsies in both cases showed adenocarcinoma metastatis immunoprofile: CK7+/TTF1+/ER-/ PR-/HER2-/GATA3-/GCDFP-/ mammaglobin-.The result supported lung origin rather than primary breast carcinoma.Microscopic images of histology samples are presented in FIGURE 1G and1H.Key features that can distinguish between metastatic and primary breast carcinoma include: absence of an in -situ component, multiplicity / bilaterality, and a lack of breast markers, such as ER/ PR/HER2/GATA3/GCDFP/mammaglobin, with positive lung markers (TTF -1).The treatment proposed by a multidisciplinary board included stereotactic radiotherapy for brain metastases, brachytherapy for ocular metastasis, and systemic therapy (chemotherapy or immunotherapy) pending molecular testing (programmed cell death ligand 1 and next generation sequencing).The patient remained clinically stable and was discharged with follow -up scheduled for oncology, ophthalmology, radiotherapy, and palliative care.The therapy consisted of paclitaxel, gemcitabine, and radiotherapy of the brain.The treatment followed current standards of care. 5etastatic breast disease originating from lung cancer is a rare clinical condition, even rarer

Polskie Archiwum Medycyny WewnętrznejVol. 136(3)
Good health and well-being
Openalex Percentile: Top 56%
Cancer Risks and Factors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.